Free Trial: Direct Access to ValuEngine Research on over 5,000 stocks and 700 ETFs HERE ...
U.S. equity markets continued to experience modest volatility this week as investors balanced geopolitical developments with ...
The results indicate that this methodology applied at the end of 2023 resulted in a strong top ten list in 2024. In a year that the Standard & Poor’s SPIVA (S&P vs. Active) blog reported that more ...
Market action last week depended heavily on where investors chose to look. Beneath largely unchanged headline index levels, sharp rotations continued across style, size, and geography. Value stocks ...
ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, ...
ValuEngine produces 12-page PDF reports every day for around 4,100 US stocks using two distinct models—a valuation model, and a forecast model that uses the valuation model but also delivers short- ...
ValuEngine is a subscription-based business intelligence, market and equity analysis firm that provides exclusive, customized research and analysis solutions directly to companies, investors, ...
ValuEngine lowered its rating on Surgery Partners’ shares from a “hold” to a “sell,” according to The Ledger Gazette. 1. Surgery Partners’ shares opened Nov. 24 trading at $8.60 per share. 2. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results